2289 — Charmacy Pharmaceutical Co Cashflow Statement
0.000.00%
- HK$928.80m
- HK$918.87m
- CNY4.40bn
- 13
- 78
- 40
- 37
Annual cashflow statement for Charmacy Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | CAS | CAS | CAS | CAS | CAS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 4.02 | 131 | -19.5 | 44.1 | -96.5 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | 4.02 | 131 | -19.5 | 44.1 | -96.5 |
Capital Expenditures | -73.9 | -52 | -25 | -8.59 | -40.8 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.16 | -2.8 | 0.638 | 80.4 | 80.2 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -73.7 | -54.8 | -24.4 | 71.8 | 39.3 |
Financing Cash Flow Items | -156 | -68.1 | -63.1 | 53.8 | 27 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 54.1 | -2.68 | 74.4 | -191 | 101 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -15.6 | 73.6 | 30.5 | -75.4 | 44.1 |